Qinglian Wen

Fujian Medical University — China

Medicine · Health Sciences

29h-index2.6kcitations93works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(16), Cancer-related molecular mechanisms research(12), Endometrial and Cervical Cancer Treatments(9), RNA modifications and cancer(8), Lung Cancer Treatments and Mutations(7)

Publications93 total

Silk fibroin-based nanocarriers for anticancer drug delivery: advances, mechanisms, and future perspectives
Nanomedicine·2025Open Access
Salvage sequential integrated boost radiotherapy followed by sintilimab–bevacizumab in cervical small-cell carcinoma with >10 brain metastases: A 3-year survivor case report
Frontiers in Immunology·2025Open Access
OA06.02 Safety and Efficacy of QLC5508 in Previously Treated Patients with Small Cell Lung Cancer: Updated Data from a Phase 1 Study
Journal of Thoracic Oncology·2025
1128P Neoadjuvant adebrelimab plus chemotherapy for locally advanced cervical cancer: A prospective, single-arm, phase II trial
Annals of Oncology·2025
Association between SII and postoperative pulmonary infection in elderly patients undergoing laparoscopic abdominal surgery
Frontiers in Medicine·2025· 3 citedOpen Access
Correction to “Bioactive Bacteria/MOF Hybrids Can Achieve Targeted Synergistic Chemotherapy and Chemodynamic Therapy Against Breast Tumors”
Advanced Functional Materials·2025Open Access
Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer
Epigenomics·2024· 1 citedOpen Access
Skin metastasis from ovarian cancer with somatic BRCA1 mutation: A case report and literature review
Oncology Letters·2024· 1 citedOpen Access
HPV-associated cervicovaginal microbiome and host metabolome characteristics
BMC Microbiology·2024· 16 citedOpen Access
Effect of Zhishenyuanhu Anticoagulant Formula on Hypercoagulability in Rats with Qi Stagnation and Blood Stasis and Arterial and Venous Thrombosis in Rats
World Journal of Social Science Research·2024Open Access
Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC?
Hepatology·2024
Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?
Frontiers in Immunology·2024· 2 citedOpen Access
Successful inguinal interstitial brachytherapy in metastatic cervical carcinoma: a case report
Frontiers in Oncology·2024· 3 citedOpen Access
Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer
Frontiers in Immunology·2024· 5 citedOpen Access
100P Phase II trial of tislelizumab plus bevacizumab and chemotherapy as the first-line therapy for persistent, recurrent, or metastatic cervical cancer: Updated efficacy and safety results
Immuno-Oncology Technology·2023Open Access
The p110α/ΔNp63α complex mutations in triple-negative breast cancer: Potential targets for transcriptional-based therapies
Tumor Biology·2023· 1 citedOpen Access
316P First evidence of olaparib maintenance therapy in patients with newly diagnosed BRCA wild-type ovarian cancer: A real-world multicenter study
Annals of Oncology·2023Open Access
760P Efficacy and safety of nimotuzumab plus radiotherapy for elderly patients with locally advanced cervical squamous cell carcinoma
Annals of Oncology·2023· 1 citedOpen Access
Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
Cell Communication and Signaling·2023· 112 citedOpen Access
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial
International Journal of Radiation Oncology*Biology*Physics·2023· 31 cited
page 1 of 5Next →

Frequent Co-authors

Zhangang Xiao(32), Yueshui Zhao(31), Mingxing Li(31), Jing Shen(27), Xu Wu(27), Fukuan Du(25), Parham Jabbarzadeh Kaboli(18), Chi Hin Cho(13), Jing Li(13), Shixin Xiang(11), Qijie Zhao(10), Huijiao Ji(9), Tao Yi(7), Saber İmani(7), Wanping Li(6), Yu Chen(6), Xiang Li(5), Meijuan Chen(5), Xiaobing Li(4), Jianhua Yin(4)